Clopidogrel affects leukocyte dependent platelet aggregation by P2Y 12 expressing leukocytes

Basic Research in Cardiology

Volumn 105, Issue 3, 2010, Pages 379-387

  Diehl, Philipp ^a   Olivier, Christoph ^a   Haischeid, Christoph ^a   Helbing, Thomas ^a   Bode, Christoph ^a   Moser, Martin ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

ASA; Clopidogrel; Non responder; P2Y12; Platelet aggregation

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; ARACHIDONIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PURINERGIC P2Y12 RECEPTOR; ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE; PURINERGIC P2 RECEPTOR; TICLOPIDINE;

AGED; ARTICLE; BODY MASS; CELL INTERACTION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; CORRELATION ANALYSIS; DEVICE; DRUG MECHANISM; DRUG RESPONSE; DRUG UNDERDOSE; FEMALE; HUMAN; LEUKOCYTE; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROTEIN EXPRESSION; THROMBOCYTE; THROMBOCYTE AGGREGATION; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY THROMBOSIS; DRUG EFFECT; METABOLISM; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASPIRIN; CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; FEMALE; HUMANS; LEUKOCYTES; MALE; OBESITY; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; RECEPTORS, PURINERGIC P2; STENTS; TICLOPIDINE;

EID: 77952764315     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-009-0073-8     Document Type: Article

References (43)

1. Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Barrera Ramirez C, Sabate M, Fernandez C, Hernandez-Antolin R, Escaned J, Alfonso F, Macaya C (2004) Platelet aggregation according to body mass index in patients undergoing coronary stenting: should Clopidogrel loading-dose be weight adjusted? J Invasive Cardiol 16:169-174
2. Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramirez C, Cavallari U, Trabetti E, Sabate M, Hernandez R, Moreno R, Escaned J, Alfonso F, Banuelos C, Costa MA, Bass TA, Pignatti PF, Macaya C (2006) Contribution of gene sequence variations of the hepatic cytochrome P450 3 A4 enzyme to variability in individual responsiveness to Clopidogrel. Arterioscler Thromb Vase Biol 26:1895-1900 (Pubitemid 44305347)
3. Angiolillo DJ, Suryadevara S (2009) Aspirin and Clopidogrel: efficacy and resistance in diabetes mellitus. Best Pract Res Clin Endocrinol Metab 23:375-388
4. Becker RC, Meade TW, Berger PB, Ezekowitz M, O'Connor CM, Vorchheimer DA, Guyatt GH, Mark DB, Harrington RA (2008) The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133:776S-814S (Pubitemid 351894917)
5. Bhatt DL (2008) What makes platelets angry: diabetes, fibrinogen, obesity, and impaired response to antiplatelet therapy? J Am Coll Cardiol 52:1060-1061
6. Bhatt DL, Flather MD, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Fabry-Ribaudo L, Hu T, Topol EJ, Fox KA (2007) Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol 49:1982-1988 (Pubitemid 46694290)
7. Bournazos S, Rennie J, Hart SP, Fox KA, Dransfield I (2008) Monocyte functional responsiveness after PSGL-I-mediated platelet adhesion is dependent on platelet activation status. Arterioscler Thromb Vase Biol 28:1491-1498
8. Brown DW, Giles WH, Croft JB (2001) White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort. J Clin Epidemiol 54:316-322
9. Buonamici P, Marcucci R, Migliorini A, Gensini GF, Santini A, Paniccia R, Moschi G, Gori AM, Abbate R, Antoniucci D (2007) Impact of platelet reactivity after Clopidogrel administration on drug-eluting stent thrombosis. J Am Coll Cardiol 49:2312-2317 (Pubitemid 46891710)
10. Cuisset T, Frere C, Quilici J, Morange PE, Camoin L, Bali L, Lambert M, Juhan-Vague I, Alessi MC, Bonnet JL (2009) Relationship between aspirin and Clopidogrel responses in acute coronary syndrome and clinical predictors of non response. Thromb Res 123:597-603
11. Danesh J, Collins R, Appleby P, Peto R (1998) Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. Jama 279:1477-1482 (Pubitemid 28228207)
12. Diehl P, Nagy F, Sossong V, Helbing T, Beyersdorf F, Olschewski M, Bode C, Moser M (2008) Increased levels of circulating microparticles in patients with severe aortic valve stenosis. Thromb Haemost 99:711-719 (Pubitemid 351694227)
13. Erlinge D, Varenhorst C, Braun OO, James S, Winters KJ, Jakubowski JA, Brandt JT, Sugidachi A, Siegbahn A, Wallentin L (2008) Patients with poor responsiveness to thienopyridine treatment or with diabetes have lower levels of circulating active metabolite, but their platelets respond normally to active metabolite added ex vivo. J Am Coll Cardiol 52:1968-1977
14. Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115:911-919 quiz 920
15. Feher G, Koltai K, Alkonyi B, Papp E, Keszthelyi Z, Kesmarky G, Toth K (2007) Clopidogrel resistance: role of body mass and concomitant medications. Int J Cardiol 120:188-192 (Pubitemid 47042251)
16. Frelinger AL 3rd, Jakubowski JA, Li Y, Barnard MR, Fox ML, Linden MD, Sugidachi A, Winters KJ, Furman MI, Michelson AD (2007) The active metabolite of prasugrel inhibits ADPstimulated thrombo-inflammatory markers of platelet activation: influence of other blood cells, calcium, and aspirin. Thromb Haemost 98:192-200 (Pubitemid 47074196)
17. Götz AK, Zahler S, Stumpf P, Welsch U, Becker BF (2005) Intracoronary formation and retention of micro aggregates of leukocytes and platelets contribute to postischemic myocardial dysfunction. Basic Res Cardiol 100:413-421 (Pubitemid 41300496)
18. Graff J, Harder S, Wahl O, Scheuermann EH, Gossmann J (2005) Anti-inflammatory effects of Clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers. Clin Pharmacol Ther 78:468-476 (Pubitemid 41698901)
19. Grau AJ, Boddy AW, Dukovic DA, Buggle F, Lichy C, Brandt T, Hacke W (2004) Leukocyte count as an independent predictor of recurrent ischemic events. Stroke 35:1147-1152 (Pubitemid 38543534)
20. Gurbel PA, Bliden KP, Hayes KM, Yoho JA, Herzog WR, Tantry US (2005) The relation of dosing to Clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting. J Am Coll Cardiol 45:1392-1396
21. Herishanu Y, Rogowski O, PoUiack A, Maritas R (2006) Leukocytosis in obese individuals: possible link in patients with unexplained persistent neutrophilia. Eur J Haematol 76:516-520
22. Hermann A, Rauch BH, Braun M, Schror K, Weber AA (2001) Platelet CD40 ligand (CD40L)-subcellular localization, regulation of expression, and inhibition by Clopidogrel. Platelets 12:74-82 (Pubitemid 32281113)
23. Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramakrishnan V, Yang RB, Nurden P, Nurden A, Julius D, Conley PB (2001) Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409:202-207 (Pubitemid 32144286)
24. Johnson A, Dovlatova N, Heptinstall S (2008) Multiple electrode aggregometry and P2Y(12) antagonists. Thromb Haemost 99:1127-1129 (Pubitemid 351810501)
25. Klinkhardt U, Bauersachs R, Adams J, Graff J, Lindhoff-Last E, Harder S (2003) Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease. Clin Pharmacol Ther 73:232-241 (Pubitemid 36269674)
26. Lau WC, Waskell LA, Watkins PB, Neer CJ, Horowitz K, Hopp AS, Tait AR, Carville DG, Guyer KE, Bates ER (2003) Atorvastatin reduces the ability of Clopidogrel to inhibit platelet aggregation: a new drug-drug interaction. Circulation 107:32-37 (Pubitemid 36070929)
27. Libby P, Simon DI (2001) Inflammation and thrombosis: the clot thickens. Circulation 103:1718-1720
28. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O'Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thorn T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y (2009) Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119:480-486 (Pubitemid 43754289)
29. Matetzky S, Shenkman B, Guetta V, Shechter M, Bienart R, Goldenberg I, Novikov I, Pres H, Savion N, Varan D, Hod H (2004) Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 109:3171-3175
30. Nijm J, Wikby A, Tompa A, Olsson AG, Jonasson L (2005) Circulating levels of proinflammatory cytokines and neutrophilplatelet aggregates in patients with coronary artery disease. Am J Cardiol 95:452-456 (Pubitemid 40247537)
31. O'Donoghue M, Morrow DA, Cannon CP, Guo W, Murphy SA, Gibson CM, Sabatine MS (2008) Association between baseline neutrophil count, Clopidogrel therapy, and clinical and angiographic outcomes in patients with ST-elevation myocardial infarction receiving fibrinolytic therapy. Eur Heart J 29:984-991
32. Pereillo JM, Maftouh M, Andrieu A, Uzabiaga MF, Fedeli O, Savi P, Pascal M, Herbert JM, Maffrand JP, Picard C (2002) Structure and stereochemistry of the active metabolite of Clopidogrel. Drug Metab Dispos 30:1288-1295 (Pubitemid 35265838)
33. Randriamboavonjy V, Badenhoop K, Schmidt H, Geisslinger G, Fisslthaler B, Fleming I (2009) The S1P(2) receptor expressed in human platelets is linked to the RhoA-Rho kinase pathway and is down regulated in type 2 diabetes. Basic Res Cardiol 104:333-340
34. Scharbert G, Kalb M, Marschalek C, Kozek-Langenecker SA (2006) The effects of test temperature and storage temperature on platelet aggregation: a whole blood in vitro study. Anesth Analg 102:1280-1284
35. Schulz C, Penz S, Hoffmann C, Langer H, Gillitzer A, Schneider S, Brandi R, Seidl S, Massberg S, Pichler B, Kremmer E, Stellos K, Schonberger T, Siess W, Gawaz M (2008) Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo. Basic Res Cardiol 103:356-367
36. Seizer P, Gawaz M, May AE (2008) Platelet-monocyte interactions-a dangerous liaison linking thrombosis, inflammation and atherosclerosis. Curr Med Chem 15:1976-1980
37. Sibbing D, Braun S, Morath T, Mehilli J, Vogt W, Schomig A, Kastrati A, von Beckerath N (2009) Platelet reactivity after Clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. J Am Coll Cardiol 53:849-856
38. Sibbing D, von Beckerath O, Schomig A, Kastrati A, von Beckerath N (2007) Impact of body mass index on platelet aggregation after administration of a high loading dose of 600 mg of Clopidogrel before percutaneous coronary intervention. Am J Cardiol 100:203-205 (Pubitemid 47041981)
39. Simon T, Verstuyft C, Mary-Krause M, Quteineh L, Drouet E, Meneveau N, Steg PG, Ferneres J, Danchin N, Becquemont L (2009) Genetic determinants of response to Clopidogrel and cardiovascular events. N Engl J Med 360:363-375
40. Steinhubl SR, Berger PB, Mann JT 3rd, Fry ET, DeLago A, Wilmer C, Topol EJ (2002) Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. Jama 288:2411-2420 (Pubitemid 35340537)
41. Taubert D, von Beckerath N, Grimberg G, Lazar A, Jung N, Goeser T, Kastrati A, Schomig A, Schomig E (2006) Impact of Pglycopratein on Clopidogrel absorption. Clin Pharmacol Ther 80:486-501
42. van Werkum JW, Heestermans AA, de Körte FI, Kelder JC, Suttorp MJ, Rensing BJ, Zwart B, Brueren BR, Koolen JJ, Dambrink JH, van't Hof AW, Verheugt FW, ten Berg JM (2009) Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 cases. Circulation 119:828-834
43. Zeller JA, Lenz A, Eschenfelder CC, Zunker P, Deuschl G (2005) Platelet-leukocyte interaction and platelet activation in acute stroke with and without preceding infection. Arterioscler Thromb Vase Biol 25:1519-1523 (Pubitemid 40923378)